| Compositions and methods for ophthalmic and/or other applications |
2023-2-15 |
2023-6-29 |
|
| Nanocrystals, compositions, and methods that aid particle transport in mucus |
2023-1-23 |
2023-5-25 |
|
| Therapeutic compounds and uses thereof |
2022-5-18 |
2023-4-13 |
|
| Urea derivatives and uses thereof |
2022-4-06 |
2022-6-22 |
|
| Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers … |
2022-3-30 |
2022-7-14 |
|
| Crystalline forms of therapeutic compounds and uses thereof |
2021-12-17 |
2022-4-07 |
|
| Pharmaceutical composition |
2021-11-04 |
2022-1-14 |
|
| Meropenem derivatives and uses thereof |
2021-7-07 |
2021-10-28 |
|
| Crystalline forms of therapeutic compounds and uses thereof |
2021-5-07 |
2021-8-26 |
|
| Crystalline forms of therapeutic compounds and uses thereof |
2021-3-10 |
2023-8-01 |
2023-8-01 |
| Therapeutic compounds and uses thereof |
2021-2-19 |
2021-12-23 |
|
| Novel Compounds and Uses Thereof |
2021-2-02 |
2021-12-09 |
|
| 1-Amino-triazolo(1,5-A)pyridine-substituted Urea Derivative and Uses Thereof |
2020-12-04 |
2021-3-25 |
|
| Pharmaceutical nanoparticles showing improved mucosal membrane transport |
2020-11-20 |
2021-3-11 |
|
| Crystalline forms of therapeutic compounds and uses thereof |
2019-7-16 |
2020-9-08 |
2020-9-08 |
| Particles, compositions, and methods for ophthalmic and/or other applications |
2019-7-03 |
2020-1-16 |
|
| Compositions and methods for ophthalmic and/or other applications |
2018-12-14 |
2020-12-15 |
2020-12-15 |
| Crystalline forms of therapeutic compounds and uses thereof |
2018-10-24 |
2019-3-14 |
|
| RET9 and VEGFR2 inhibitors |
2018-10-19 |
2020-7-28 |
|
| Particles, compositions, and methods for ophthalmic and/or other applications |
2017-9-15 |
2018-3-22 |
|
| Particles, compositions, and methods for ophthalmic and/or other applications |
2017-9-15 |
2019-3-21 |
|
| Particles, Compositions and Methods for Ophthalmic and/or Other Applications |
2017-9-15 |
2019-7-18 |
|
| Compositions and methods comprising medium chain triglycerides for treatment of … |
2017-8-30 |
2020-6-02 |
2020-6-02 |
| Crystalline Forms of Therapeutic Compounds and Uses Thereof |
2017-5-24 |
2017-9-14 |
|
| Crystalline forms of a therapeutic compound and uses thereof |
2015-11-24 |
2017-11-02 |
|
| Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6- … |
2014-11-03 |
2017-6-27 |
2017-6-27 |
| Therapeutic compounds and uses thereof |
2014-2-18 |
2017-7-04 |
2017-7-04 |
| Pharmaceutical nanoparticles showing improved mucosal transport |
2013-5-03 |
2017-12-22 |
|
| Fluid density from downhole optical measurements |
2013-5-03 |
2016-1-26 |
2016-1-26 |
| Compositions and methods for enhancing transport through mucus |
2007-9-07 |
2010-8-26 |
|
| Functionalized poly (ether-anhydride) block copolymers |
2005-12-09 |
2006-6-15 |
|
| Drugs and gene carrier particles that rapidly move through mucous barriers |
2005-1-28 |
2015-2-17 |
2015-2-17 |